NCT04987008 (EPIC-FOPCohort) is a clinical trial in Foramen Ovale, Patent, sponsored by University Hospital, Brest.

Who is sponsoring NCT04987008?

NCT04987008 is sponsored by University Hospital, Brest.

What condition does NCT04987008 study?

NCT04987008 studies Foramen Ovale, Patent.

Is NCT04987008 still recruiting?

NCT04987008 is currently status unknown. Last updated 3 August 2021.

Last reviewed 2021-08-03 · How we verify

NCT04987008: EPIC-FOPCohort

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk of Ischaemic Stroke After Pulmonary Embolism in Patients With and Without Patent Foramen Ovale

Status unknown Last updated 3 August 2021

What this trial tests

trial in Foramen Ovale, Patent in 53 participants. Status unknown.

Timeline

18 May 2021

Primary endpoint
31 August 2021

31 August 2021

Quick facts

Lead sponsor	University Hospital, Brest
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	53
Start date	18 May 2021
Primary completion	31 August 2021
Estimated completion	31 August 2021
Sites	3 locations across France

Conditions studied

Foramen Ovale, Patent — all drugs for Foramen Ovale, Patent →

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with Foramen Ovale, Patent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

stroke's risk is increased in patients with pulmonary embolism and PFO compared to patients without PFO. Does this increased risk persist years after pulmonary embolism ?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Foramen Ovale, Patent

Currently open trials in the same condition.

NCT04881578 — Atrial Fibrillation Before and After Patent Foramen Ovale Closure Study · active not recruiting
NCT04339699 — NobleStitch EL STITCH Trial is a PFO Comparative Trial · NA · recruiting

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04987008 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 3 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04987008.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing